NCT00343525View on ClinicalTrials.gov

Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2007

Conditions
Hepatitis C
Interventions
DRUG

bavituximab

Trial Locations (2)

34243

University Hepatitis Center at Bach & Godofsky MD PA, Sarasota

78215

Alamo Medical Research, San Antonio

Sponsors
All Listed Sponsors
lead

Peregrine Pharmaceuticals

INDUSTRY